Verona Pharma plc

Verona Pharma plc - ROEverified

VRNA

Price:

$106.91

Market Cap:

$72.68B

Verona Pharma plc is a biopharmaceutical company currently in its clinical development phase, focusing on the research, development, and eventual market launch of new therapies for respiratory illnesses where current treatments are inadequate. Its primary experimental medication is ensifentrine, an inhaled compound designed to simultaneously block both phosphodiesterase (PDE) 3 and PDE4 enzymes. This unique mechanism allows it to function both as a bronchodilator, helping to open the airways, and as an anti-inflammatory agent within a single drug. Ensifentrine is presently undergoing advanced (Phase 3) clinical trials to evaluate its effectiveness in treating chronic obstructive pulmonary di...[Read more]

Industry

Biotechnology

IPO Date

2017-04-28

Stock Exchange

NASDAQ

Ticker

VRNA

The ROE as of August 2026 (TTM) for Verona Pharma plc (VRNA) is -1.56%

According to Verona Pharma plc’s latest financial reports and current stock price. The company's current ROE is -1.56%. This represents a change of -84.48% compared to the average of -10.07% of the last 4 quarters.

Verona Pharma plc (VRNA) Historical ROE (quarterly & annually)

How has VRNA ROE performed in the past?

The mean historical ROE of Verona Pharma plc over the last ten years is -45.80%. The current -1.56% ROE has changed -96.59% with respect to the historical average. Over the past ten years (40 quarters), VRNA's ROE was at its highest in in the September 2021 quarter at 4.88%. The ROE was at its lowest in in the December 2015 quarter at -35.03%.

Quarterly (TTM)
Annual

Average

-45.80%

Median

-26.77%

Minimum

-137.94%

Maximum

-11.80%

Verona Pharma plc (VRNA) ROE by Quarter and Year

Discovering the peaks and valleys of Verona Pharma plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 530.22%

Maximum Annual ROE = -11.80%

Minimum Annual Increase = -91.44%

Minimum Annual ROE = -137.94%

Quarterly (TTM)
Annual
YearROEChange
2024-67.71%295.79%
2023-17.11%-30.62%
2022-24.66%-11.18%
2021-27.76%7.73%
2020-25.77%-72.84%
2019-94.90%202.41%
2018-31.38%65.27%
2017-18.99%60.88%
2016-11.80%-91.44%
2015-137.94%530.22%

Verona Pharma plc (VRNA) Average ROE

How has VRNA ROE performed in the past?

The current ROE of Verona Pharma plc (VRNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-36.49%

5-year avg

-32.60%

10-year avg

-45.80%

Verona Pharma plc (VRNA) ROE vs. Peers

How is VRNA’s ROE compared to its peers?

Verona Pharma plc’s ROE is greater than Seagen Inc. (-20.80%), less than Becton, Dickinson and Company (3.79%), greater than Alpine Immune Sciences, Inc. (-12.69%), greater than ImmunoGen, Inc. (-92.61%), less than BeOne Medicines AG (14.27%), greater than Prometheus Biosciences, Inc. (-31.12%), less than Reata Pharmaceuticals, Inc. (47.21%), greater than ERYTECH Pharma S.A. (-95.68%), greater than Karuna Therapeutics, Inc. (-36.44%), greater than Blueprint Medicines Corporation (-31.26%),

Build a custom stock screener for Verona Pharma plc (VRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verona Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verona Pharma plc (VRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verona Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Verona Pharma plc's ROE?

How is the ROE calculated for Verona Pharma plc (VRNA)?

What is the highest ROE for Verona Pharma plc (VRNA)?

What is the 3-year average ROE for Verona Pharma plc (VRNA)?

What is the 5-year average ROE for Verona Pharma plc (VRNA)?

How does the current ROE for Verona Pharma plc (VRNA) compare to its historical average?